Pluri Inc. (Nasdaq: PLUR, TASE: PLUR) announced that its majority-owned food-tech subsidiary, Ever After Foods Ltd. (EAF), has acquired Fishway BV, a Belgium-based biotechnology company specializing in aquatic cell biology and animal-component-free (ACF) media development for the cultivated-protein industry.

The acquisition adds Fishway's capabilities in aquatic cell biology and ACF media development to EAF's existing bioprocess and manufacturing platform. Fishway also provides EAF with an established scientific presence in Belgium, extending its European footprint.

In connection with the acquisition, EAF secured an additional $2 million strategic investment through a simple agreement for future equity (SAFE Agreement) to support ongoing platform development and commercialization activities.

EAF operates an open manufacturing platform for the cultivated-protein industry, integrating biology, media, bioprocess engineering, and advanced manufacturing technologies.

"Fishway adds strong capabilities in aquatic cell biology and animal-component-free media that complement Ever After Foods' production platform and expand the range of applications we can support," said Eyal Rosenthal, CEO of Ever After Foods.

Yaky Yanay, President and CEO of Pluri, said Fishway "brings complementary science, talent and a European base to EAF," adding that the move is intended to strengthen EAF's ability to support customers moving toward commercial-scale cultivated protein production.